Image de couverture de livre

Concordance with final pathology when transitioning from standard transrectal to cognitive targeted transperineal prostate biopsy

Fuente: Wiley Open Access

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Alfred Honoré, Karsten Gravdal, Patrick Juliebø‐Jones, Lars Anders Rokne Reisæter, Christian Beisland, Christian Arvei Moen
Format:	Artículo Open Access
Publié:	Wiley 2025
Sujets:	BJUI Compass
Accès en ligne:	Acceder al recurso
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

The carbon footprint of transperineal prostate biopsy
par: Daniel A. Carson, et autres
Publié: (2025)

Perioperative antibiotic prophylaxis, prostate size and transperineal prostate biopsy
par: Maxwell Louis Sandberg, et autres
Publié: (2026)

The past, present and future of penile cancer in the Nordic countries. Results from NORDCAN
par: Christian Arvei Moen, et autres
Publié: (2025)

Impact of multiparametric MRI and prostate biopsies on anxiety and quality of life in men with suspected prostate cancer
par: Esther H. J. Hamoen, et autres
Publié: (2025)

Quantification of perineural invasion on prostate biopsy improves risk stratification in biopsy Grade Group 2–3 cancer
par: Yuki Teramoto, et autres
Publié: (2026)

Clinical validation of a biopsy‐based six‐gene signature prognostic for aggressive prostate cancer
par: Agnieszka Krzyzanowska, et autres
Publié: (2024)

Risk factors of negative prostate biopsies: A CHAID decision tree analysis
par: Pierre Allainguillaume, et autres
Publié: (2026)

AI‐enhanced micro‐ultrasound improves detection of clinically significant prostate cancer at biopsy
par: Muhammad Imran, et autres
Publié: (2026)

Perioperative alpha blockers in voiding dysfunction secondary to prostate biopsy: A meta‐analysis
par: Sean Lim, et autres
Publié: (2024)

Contemporary assessment of diagnostic performance and histologic concordance of renal mass biopsy with surgical pathology
par: Mitchell M. Huang, et autres
Publié: (2025)

Transperineal prostate biopsy with freehand technique under local anaesthetic: A systematic review and meta‐analysis
par: Benjamin M. Mac Curtain, et autres
Publié: (2025)

The impact of pre‐biopsy MRI and additional testing on prostate cancer screening outcomes: A rapid review
par: Abel Tesfai, et autres
Publié: (2024)

Omission of contralateral biopsies in unilateral MRI‐suspicious prostate cancer has minimal impact on clinical risk assessment
par: Stijn M. van den Bosch, et autres
Publié: (2026)

Cost‐effectiveness analysis of a biopsy‐free diagnostic strategy for prostate cancer using mpMRI and PSMA‐PET/CT
par: Joshua Yi Min Tung, et autres
Publié: (2026)

Performance and safety of transverse scrotal vs transperineal AUS for PPUI: A retrospective cohort study
par: Christine R. Reus, et autres
Publié: (2025)

The impact of biopsy core length on the discrepancy in Gleason scores between biopsy and radical prostatectomy specimen
par: Cheng‐hao Guo, et autres
Publié: (2025)

Genomic prostate score and treatment selection in favourable intermediate‐risk prostate cancer
par: Eric Margolis, et autres
Publié: (2025)

A machine learning algorithm for automatic tumour board recommendations in prostate cancer patients
par: Marcus Sondermann, et autres
Publié: (2025)

A modified Delphi consensus statement on the role of biopsy in small renal masses
par: Darryl E. Bernstein, et autres
Publié: (2025)

Emerging tools for the early detection of prostate cancer
par: Muhammad Haider, et autres
Publié: (2025)

Quality of English‐ and Spanish‐language online content about prostate cancer genetics: Insights into potential contributors to prostate cancer disparities
par: Sophia M. Abusamra, et autres
Publié: (2025)

Variation in harms and benefits of prostate‐specific antigen screening for prostate cancer by socio‐clinical risk factors: A rapid review
par: Abel Tesfai, et autres
Publié: (2024)

Comparing outcomes of Aquablation versus holmium laser enucleation of prostate in the treatment of benign prostatic hyperplasia: A network meta‐analysis
par: Ansh Bhatia, et autres
Publié: (2024)

Bibliometric analysis of focal therapy in prostate cancer research
par: Mohammed Shahait, et autres
Publié: (2024)

Multivariable model integrating PHI and mpMRI for detecting csPCa in biopsy‐naïve men
par: Mario Dominguez Esteban, et autres
Publié: (2025)

‘It Just Makes Sense to Me’: A qualitative study exploring patient decision‐making and experiences with prostate MRI during active surveillance for prostate cancer
par: Ryan Sutherland, et autres
Publié: (2024)

Micro‐ultrasound tissue echogenicity predicts prostate cancer grade
par: Ailene E. Corona, et autres
Publié: (2026)

The impact of vaporization on adenoma weight in benign prostatic hyperplasia surgery
par: André B. Silva, et autres
Publié: (2026)

Targeting genomic receptors in voided urine for confirmation of benign prostatic hyperplasia
par: Mathew Thakur, et autres
Publié: (2024)

Utility of dynamic contrast enhancement for clinically significant prostate cancer detection
par: Eric V. Li, et autres
Publié: (2024)

National survey of urologists' views on prostate cancer screening in the United Kingdom
par: Nikhil Mayor, et autres
Publié: (2026)

Focal therapy in prostate cancer: Development, application and outcomes in the United Kingdom
par: Nadia Rokan, et autres
Publié: (2025)

Multidisciplinary meetings for lower urinary tract symptoms and benign prostate hyperplasia
par: Emilien Seizilles de Mazancourt, et autres
Publié: (2025)

Investigating the prognostic utility of GSTP1 promoter methylation in prostate cancer
par: Ruth Pidsley, et autres
Publié: (2024)

WATER versus WATER II 5‐year update: Comparing Aquablation therapy for benign prostatic hyperplasia in 30–80‐cm3 and 80–150‐cm3 prostates
par: Mohamad Baker Berjaoui, et autres
Publié: (2024)

The significant costs of prostate cancer management—An analysis from a Caribbean hospital
par: Geneva Pantoja, et autres
Publié: (2025)

Impact of recreational football in men with prostate cancer undergoing androgen deprivation therapy
par: Sofia Mesquita, et autres
Publié: (2025)

Evaluating the utility of the HAS‐BLED bleeding‐estimator tool for transurethral resection of prostate
par: Lu Yu Kuo, et autres
Publié: (2025)

Does total lesion prostate‐specific membrane antigen (PSMA) activity on 68Ga‐PSMA PET/CT correlate with PSA and prostatectomy histopathological/clinical outcomes in patients with localised primary prostate cancer?
par: Jeremy Cheng, et autres
Publié: (2025)

Real‐world clinical outcomes of oligometastatic prostate cancer using SBRT: An Australian experience
par: Samantha Shekar, et autres
Publié: (2025)